Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?

Author： McIntyre Roger S   Soczynska Joanna K   Woldeyohannes Hanna O   Lewis Gary F   Leiter Lawrence A   MacQueen Glenda M   Miranda Andrew   Fulgosi Don   Konarski Jakub Z   Kennedy Sidney H  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.8, Iss.11, 2007-08, pp. : 1615-1628

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?

By  

Current Neuropharmacology, Vol. 13, Iss. 5, 2015-09 ,pp. : 663-680

Bentham Science Publishers

Access to resources Recommend Favorite

Glia mechanisms in mood regulation: a novel model of mood disorders

By Lee Younglim   Gaskins Denise   Anand Amit   Shekhar Anantha  

Psychopharmacology, Vol. 191, Iss. 1, 2007-03 ,pp. : 55-65

Springer Publishing Company

Access to resources Recommend Favorite

Galanin Receptor Antagonists: A Potential Novel Pharmacological Treatment for Mood Disorders

By Ögren Sven Ove   Kuteeva Eugenia   Hökfelt Tomas   Kehr Jan  

CNS Drugs, Vol. 20, Iss. 8, 2006-01 ,pp. : 633-654

Adis International

Access to resources Recommend Favorite

Targeting Glutamatergic Signaling for the Development of Novel Therapeutics for Mood Disorders

By  

Current Pharmaceutical Design, Vol. 15, Iss. 14, 2009-05 ,pp. : 1595-1611

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Glycogen Synthase Kinase-3 in the CNS: Implications for the Development of New Treatments for Mood Disorders

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1399-1409

Bentham Science Publishers

Access to resources Recommend Favorite